BP to Acquire Cellulosic Biofuels Business from Verenium: An Attempt to Bail Out its Partner Company

BP p.l.c., an energy company, entered into an agreement to acquire a cellulosic biofuels business, including facilities, from the Verenium Corporation, a developer of cellulosic ethanol technology, for a purchase consideration of $98.3m. Under the agreement, BP will acquire the facilities located in Jennings, Louisiana, the US, including a pilot plant and a demonstration-scale facility and R&D facilities in San Diego, California, the US, as well as cellulosic biofuels technology, cellulosic enzyme technology and related Intellectual Property (IP). Verenium, which develops enzymes for various industries, is acquiring huge debts. The company’s bioethanol business is not generating much revenue, which is proving detrimental to the company. Therefore, the company has decided to focus on its enzyme business and sell off its biofuel business. In contrast, BP is planning to increase its investments in the renewable energy sector.

Scope

1. The information related to the bioethanol asset transaction from Verenium to BP.

2. 2. A brief on companies, Verenium and Exergy.

3. 3. Comparison of similar deals by oil and gas companies in biofuel sector in the US.

4. 4. The rationale behind the acquisition. This includes,

· The future growth path of Verenium.

· The investment plans of BP in altenative energy sector.

5. 5. Information related to the assets involved in the deal.

Reasons to buy

The Deal Report attempts to focus on the reason behind the acquisition. It will allow the reader to,

1. 1. Understand the reason which made Verenium to sell the biofuel business.

2. 2. Understand the motive behind BP buying the biofuel business from Verenium.

Table of Contents

N/A

List of Tables

N/A

List of Figures

N/A

    Pricing

Discounts available for multiple purchases.

reportstore@globaldata.com
+44 20 7947 2745

Join our mailing list

Saved reports